Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin

Share:
Related TARO
The Coming Drug-Patent Cliff Is Pushing This Portfolio Up
5 NYSE Healthcare Stocks With The Highest ROI
Related UTHR
Benzinga's M&A Chatter for Wednesday August 19, 2015
US Stock Futures Flat Ahead Of Housing Data
IBD 50 Endures Tough Week; Some Charts Intact, Others Not (Investor's Business Daily)

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at Taro Pharmaceutical Industries (NYSE: TARO) is 53.10%. Taro Pharmaceutical's revenue for the same period is $665.00 million.

The trailing-twelve-month operating margin at United Therapeutics (NASDAQ: UTHR) is 41.95%. United Therapeutics' PEG ratio is 1.77.

The trailing-twelve-month operating margin at Endo Health Solutions (NASDAQ: ENDP) is 30.09%. Endo Health had $505.61 million in total cash for the latest quarter.

The trailing-twelve-month operating margin at Cubist Pharmaceuticals (NASDAQ: CBST) is 19.25%. Cubist Pharmaceuticals' ROE for the same period is 10.23%.

Posted-In: Drug Manufacturers-Other Industry Mid-Cap Operating MarginTrading Ideas

 

Related Articles (CBST + ENDP)

Get Benzinga's Newsletters